ILC-P3-PAN
Showing 1 - 25 of 2,163
Pancreatic Ductal Adenocarcinoma Trial in Seoul (Immuncell-LC, Gemcitabine)
Recruiting
- Pancreatic Ductal Adenocarcinoma
-
Seoul, Daehak-ro, Jongno-gu, Korea, Republic ofSeoul National University Hospital
Nov 18, 2021
Anterior Cruciate Ligament Injury, Anterior Cruciate Ligament Reconstruction, Joint Instability Trial in Worldwide (Anterior
Recruiting
- Anterior Cruciate Ligament Injury
- +2 more
- Anterior cruciate ligament reconstruction (ACLR)
- Lateral extra-articular tenodesis (LET)
-
Redwood City, California
- +25 more
Dec 19, 2022
Metastatic Breast Cancer, Lobular Breast Carcinoma Trial in San Francisco (Blood Specimen)
Not yet recruiting
- Metastatic Breast Cancer
- Lobular Breast Carcinoma
- Blood Specimen
-
San Francisco, CaliforniaUniversity of California, San Francisco
Jul 19, 2023
Pneumococcal Infections, Pneumonia, Pneumococcal Trial in United States (Prevnar 13, AFX3772)
Recruiting
- Pneumococcal Infections
- Pneumonia, Pneumococcal
- Prevnar 13
- AFX3772
-
Jonesboro, Arkansas
- +31 more
Jan 19, 2023
PaCIFiC-CUP Classifies Cancer of Unknown Primary
Recruiting
- Unknown Primary Tumors
- DNA Methylation
-
Guangzhou, Guangdong, ChinaSun Yat-sen university cancer center
Nov 20, 2023
Pregnancy, Infants, Disparities Trial in Birmingham (Digital Health intervention, Community Health Worker, Digital Health
Recruiting
- Pregnancy
- +2 more
- Digital Health intervention
- +2 more
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Jul 14, 2023
Post-ERCP Acute Pancreatitis Trial in San Francisco, Philadelphia
Active, not recruiting
- Post-ERCP Acute Pancreatitis
-
San Francisco, California
- +1 more
Jul 22, 2022
Antigen-specific T Cells in Antisynthetase Syndrome and
Not yet recruiting
- Antisynthetase Syndrome
- BAL antigen-specific Th1 cells and Th17 cells, ILC and MAIT
-
Dijon, France
- +5 more
Aug 2, 2023
Immunity, Innate, Colorectal Cancer Trial in Montreal (IVDD for NK cell activity in whole blood)
Terminated
- Immunity, Innate
- Colorectal Cancer
- IVDD for NK cell activity in whole blood
-
Montreal, Quebec, Canada
- +2 more
Jan 30, 2023
Sexually Transmitted Diseases, Safe Sex, Adherence, Medication Trial in United States (P3, P3+, Control)
Completed
- Sexually Transmitted Diseases
- +2 more
- P3
- +2 more
-
Tampa, Florida
- +8 more
Oct 4, 2022
Pan Immune Inflammatory Index and Endometriosis
Active, not recruiting
- Relationship Between Pan Immune Inflammatory Index and Endometriosis and Endometriosis Stages
-
Ankara, Yenimahalle, TurkeyAnkara Etlik City Hospital
Nov 16, 2023
Type 1 Diabetes, Type 2 Diabetes Trial in Neuss (sotagliflozin (SAR439954))
Completed
- Type 1 Diabetes Mellitus
- Type 2 Diabetes Mellitus
- sotagliflozin (SAR439954)
-
Neuss, GermanyInvestigational Site Number 276001
Apr 5, 2022
Premature Birth, Decision Making, Prenatal Care Trial in Milwaukee (Preemie Prep for Parents (P3) Outpatient Mobile
Completed
- Premature Birth
- +4 more
- Preemie Prep for Parents (P3) Outpatient Mobile Intervention
- ACOG links
-
Milwaukee, WisconsinFroedtert Hospital
Apr 18, 2022
Geriatric Rehabilitation After COVID-19 Disease
Completed
- COVID-19
-
Nové Město, Czechia
- +50 more
Feb 28, 2023
Tumor, Solid Trial in Caen, Lille (RCMI in painting dose on histoscannographic mapping, Standard pan-sinusal IMRT)
Not yet recruiting
- Tumor, Solid
- RCMI in painting dose on histoscannographic mapping
- Standard pan-sinusal IMRT
-
Caen, France
- +2 more
Jul 5, 2023
Solid Tumor, EGFR Amplification Trial in Tianjin (Nimotuzumab)
Recruiting
- Solid Tumor
- EGFR Amplification
-
Tianjin, Tianjin, ChinaTianjin Medical University Second Hospital
Aug 28, 2023
Solid Tumor, FGF Receptor Gene Mutation, FGF Amplification Trial in Tianjin (Pemigatinib)
Recruiting
- Solid Tumor
- +4 more
-
Tianjin, Tianjin, ChinaTianjin Medical University Second Hospital
Aug 28, 2023
Cancer, Cancer Gene Mutation, PAN Gene Mutation Trial in Scottsdale, Jacksonville, Rochester (Pan-genomic Testing)
Not yet recruiting
- Cancer
- +2 more
- Pan-genomic Testing
-
Scottsdale, Arizona
- +2 more
Aug 18, 2023
Diabetes, Type 2 Trial (Methodological intervention, Toujeo)
Not yet recruiting
- Diabetes Mellitus, Type 2
- Methodological intervention
- Toujeo
- (no location specified)
Mar 21, 2023
Usability of Cellworks Singula™ and Cellworks Ventura™ Reports
Recruiting
- Cancer
- +2 more
- Cellworks Report
-
Sioux Falls, South DakotaAvera Cancer Institute
Jan 20, 2023